LIFE BIOSCIENCES
Live / Applied — Fourth extension granted (statement of use) (as of 27 Jan 2026)
What this means for you
Not registered yet, but its 23 May 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97424475
- Mark type
- Stylized text
- Filed
- 23 May 2022
- Published for opposition
- 19 Dec 2023
- Attorney of record
- Brendan J. Hughes
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for prevention and treatment of diseases, disorders, and degenerative conditions associated with aging, namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, and sensory diseases, disorders and conditions; Pharmaceutical preparations for the diagnosis, prevention and treatment of chronic diseases, conditions and functional disorders namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, sensory diseases, conditions, and disorders; Pharmaceutical preparations for diagnosis, prevention and treatment of diseases by gene therapy, namely, auditory, bone, cardiovascular, central nervous system, dermatological, endocrine, genetic, hematological, hepatological, immunological, gastrointestinal, genitourinary, gynecological, metabolic, musculoskeletal, nephrological, neurological, oncological, ophthalmic, psychiatric, pulmonary, renal, respiratory, urological, joint, integumentary, reproductive, otolaryngological, sensory diseases; neutraceuticals and cosmeceuticals both for use as a dietary supplement that mitigate aging, treat immunological diseases and degenerative conditions of the body, promote life extension, and restore bodily functions
- Class 044 — Medical, beauty and agricultural services: Medical diagnostics services; medical services for the diagnosis of diseases, disorders and degenerative conditions associated with aging
Owner
- Life Biosciences Inc., Boston, MA, US
- Life Biosciences Inc., Boston, MA, US
Prosecution history
- 28 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jan 2026 — SOU EXTENSION 4 GRANTED
- 27 Jan 2026 — SOU EXTENSION 4 FILED
- 27 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Jul 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jul 2025 — SOU EXTENSION 3 GRANTED
- 24 Jul 2025 — SOU EXTENSION 3 FILED
- 24 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 18 Dec 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2024 — SOU EXTENSION 2 GRANTED
- 18 Dec 2024 — SOU EXTENSION 2 FILED
- 18 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 05 Aug 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 Aug 2024 — SOU EXTENSION 1 GRANTED
- 05 Aug 2024 — SOU EXTENSION 1 FILED